57 related articles for article (PubMed ID: 8519689)
1. Activation of the mitogen-activated protein kinase cascade in response to the temperature inducible expression of v-mos kinase.
Topol LZ; Blair DG
Cell Growth Differ; 1995 Sep; 6(9):1119-27. PubMed ID: 8519689
[TBL] [Abstract][Full Text] [Related]
2. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
3. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
[TBL] [Abstract][Full Text] [Related]
4. Adhesion-dependency of serum-induced p42/p44 MAP kinase activation is released by retroviral oncogenes.
Inoue H; Yamashita A; Hakura A
Virology; 1996 Nov; 225(1):223-6. PubMed ID: 8918550
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
6. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
Gopalbhai K; Meloche S
J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
8. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.
Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K
Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044
[TBL] [Abstract][Full Text] [Related]
9. Similarities between somatic cells overexpressing the mos oncogene and oocytes during meiotic interphase.
Fukasawa K; Murakami MS; Blair DG; Kuriyama R; Hunt T; Fischinger P; Vande Woude GF
Cell Growth Differ; 1994 Oct; 5(10):1093-103. PubMed ID: 7848911
[TBL] [Abstract][Full Text] [Related]
10. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin.
Chao TS; Abe M; Hershenson MB; Gomes I; Rosner MR
Cancer Res; 1997 Aug; 57(15):3168-73. PubMed ID: 9242445
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Xenopus oocyte mitogen-activated protein kinase pathway by Mos is independent of Raf.
Shibuya EK; Morris J; Rapp UR; Ruderman JV
Cell Growth Differ; 1996 Feb; 7(2):235-41. PubMed ID: 8822207
[TBL] [Abstract][Full Text] [Related]
12. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
[TBL] [Abstract][Full Text] [Related]
13. Mos proto-oncogene function during oocyte maturation in Xenopus.
Roy LM; Haccard O; Izumi T; Lattes BG; Lewellyn AL; Maller JL
Oncogene; 1996 May; 12(10):2203-11. PubMed ID: 8668347
[TBL] [Abstract][Full Text] [Related]
14. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
Greulich H; Reichman C; Hanafusa H
Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
[TBL] [Abstract][Full Text] [Related]
15. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
16. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
[TBL] [Abstract][Full Text] [Related]
17. Functions of the mos oncogene family and associated gene products.
Bold RJ; Hannink M; Donoghue DJ
Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
[TBL] [Abstract][Full Text] [Related]
18. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
19. Ser-3 is important for regulating Mos interaction with and stimulation of mitogen-activated protein kinase kinase.
Chen M; Cooper JA
Mol Cell Biol; 1995 Sep; 15(9):4727-34. PubMed ID: 7651390
[TBL] [Abstract][Full Text] [Related]
20. Potassium inhibition of transforming protein P85gag-mos and reversal of the transformed phenotype in 6m2 cells.
Lai CN; Gallick GE; Maxwell SA; Brinkley BR; Becker FF
J Cell Physiol; 1988 Mar; 134(3):445-52. PubMed ID: 2965157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
